BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 28899863)

  • 1. A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles.
    Rebecca VW; Nicastri MC; McLaughlin N; Fennelly C; McAfee Q; Ronghe A; Nofal M; Lim CY; Witze E; Chude CI; Zhang G; Alicea GM; Piao S; Murugan S; Ojha R; Levi SM; Wei Z; Barber-Rotenberg JS; Murphy ME; Mills GB; Lu Y; Rabinowitz J; Marmorstein R; Liu Q; Liu S; Xu X; Herlyn M; Zoncu R; Brady DC; Speicher DW; Winkler JD; Amaravadi RK
    Cancer Discov; 2017 Nov; 7(11):1266-1283. PubMed ID: 28899863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Antimalarials and Antineoplastic Drugs can Interact in Combination Therapies: A Perspective on the Role of PPT1 Enzyme.
    Duarte D; Vale N
    Curr Drug Metab; 2021; 22(13):1009-1016. PubMed ID: 34791996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer.
    Rebecca VW; Nicastri MC; Fennelly C; Chude CI; Barber-Rotenberg JS; Ronghe A; McAfee Q; McLaughlin NP; Zhang G; Goldman AR; Ojha R; Piao S; Noguera-Ortega E; Martorella A; Alicea GM; Lee JJ; Schuchter LM; Xu X; Herlyn M; Marmorstein R; Gimotty PA; Speicher DW; Winkler JD; Amaravadi RK
    Cancer Discov; 2019 Feb; 9(2):220-229. PubMed ID: 30442709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimeric quinacrines as chemical tools to identify PPT1, a new regulator of autophagy in cancer cells.
    Nicastri MC; Rebecca VW; Amaravadi RK; Winkler JD
    Mol Cell Oncol; 2018; 5(1):e1395504. PubMed ID: 29404393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosome Membrane Permeabilization and Disruption of the Molecular Target of Rapamycin (mTOR)-Lysosome Interaction Are Associated with the Inhibition of Lung Cancer Cell Proliferation by a Chloroquinoline Analog.
    Sironi J; Aranda E; Nordstrøm LU; Schwartz EL
    Mol Pharmacol; 2019 Jan; 95(1):127-138. PubMed ID: 30409790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Lysosome for Cancer Therapy.
    Towers CG; Thorburn A
    Cancer Discov; 2017 Nov; 7(11):1218-1220. PubMed ID: 29097619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion.
    Zhou J; Tan SH; Nicolas V; Bauvy C; Yang ND; Zhang J; Xue Y; Codogno P; Shen HM
    Cell Res; 2013 Apr; 23(4):508-23. PubMed ID: 23337583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma
    Brun S; Bestion E; Raymond E; Bassissi F; Jilkova ZM; Mezouar S; Rachid M; Novello M; Tracz J; Hamaï A; Lalmanach G; Vanderlynden L; Legouffe R; Stauber J; Schubert T; Plach MG; Courcambeck J; Drouot C; Jacquemot G; Serdjebi C; Roth G; Baudoin JP; Ansaldi C; Decaens T; Halfon P
    Autophagy; 2022 Mar; 18(3):678-694. PubMed ID: 34740311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloroquine and bafilomycin A mimic lysosomal storage disorders and impair mTORC1 signalling.
    Fedele AO; Proud CG
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32285908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib.
    Goodall ML; Wang T; Martin KR; Kortus MG; Kauffman AL; Trent JM; Gately S; MacKeigan JP
    Autophagy; 2014 Jun; 10(6):1120-36. PubMed ID: 24879157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antimalarial amodiaquine causes autophagic-lysosomal and proliferative blockade sensitizing human melanoma cells to starvation- and chemotherapy-induced cell death.
    Qiao S; Tao S; Rojo de la Vega M; Park SL; Vonderfecht AA; Jacobs SL; Zhang DD; Wondrak GT
    Autophagy; 2013 Dec; 9(12):2087-102. PubMed ID: 24113242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of lysosome function induces autophagy via a feedback down-regulation of MTOR complex 1 (MTORC1) activity.
    Li M; Khambu B; Zhang H; Kang JH; Chen X; Chen D; Vollmer L; Liu PQ; Vogt A; Yin XM
    J Biol Chem; 2013 Dec; 288(50):35769-80. PubMed ID: 24174532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of lysosomes activates the MTORC1 signaling pathway in chondrocytes in an autophagy-independent manner.
    Newton PT; Vuppalapati KK; Bouderlique T; Chagin AS
    Autophagy; 2015; 11(9):1594-607. PubMed ID: 26259639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPT1 inhibition enhances the antitumor activity of anti-PD-1 antibody in melanoma.
    Sharma G; Ojha R; Noguera-Ortega E; Rebecca VW; Attanasio J; Liu S; Piao S; Lee JJ; Nicastri MC; Harper SL; Ronghe A; Jain V; Winkler JD; Speicher DW; Mastio J; Gimotty PA; Xu X; Wherry EJ; Gabrilovich DI; Amaravadi RK
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32780726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer properties of bisaminoquinolines with modified linkers.
    Wang Y; Jain V; Versace A; Bhardwaj M; Crissey MAS; Amaravadi RK; Winkler JD
    Bioorg Med Chem Lett; 2021 Oct; 49():128272. PubMed ID: 34298133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ppt1-deficiency dysregulates lysosomal Ca
    Mondal A; Appu AP; Sadhukhan T; Bagh MB; Previde RM; Sadhukhan S; Stojilkovic S; Liu A; Mukherjee AB
    J Inherit Metab Dis; 2022 May; 45(3):635-656. PubMed ID: 35150145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pan erbB inhibitor PD168393 enhances lysosomal dysfunction-induced apoptotic death in malignant peripheral nerve sheath tumor cells.
    Kohli L; Kaza N; Lavalley NJ; Turner KL; Byer S; Carroll SL; Roth KA
    Neuro Oncol; 2012 Mar; 14(3):266-77. PubMed ID: 22259051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired TFEB-mediated lysosomal biogenesis promotes the development of pancreatitis in mice and is associated with human pancreatitis.
    Wang S; Ni HM; Chao X; Wang H; Bridges B; Kumer S; Schmitt T; Mareninova O; Gukovskaya A; De Lisle RC; Ballabio A; Pacher P; Ding WX
    Autophagy; 2019 Nov; 15(11):1954-1969. PubMed ID: 30894069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosomal pH Plays a Key Role in Regulation of mTOR Activity in Osteoclasts.
    Hu Y; Carraro-Lacroix LR; Wang A; Owen C; Bajenova E; Corey PN; Brumell JH; Voronov I
    J Cell Biochem; 2016 Feb; 117(2):413-25. PubMed ID: 26212375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMDE-1 is a dual function chemical for autophagy activation and inhibition.
    Li M; Yang Z; Vollmer LL; Gao Y; Fu Y; Liu C; Chen X; Liu P; Vogt A; Yin XM
    PLoS One; 2015; 10(3):e0122083. PubMed ID: 25894744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.